Showing results (31-40 of 43) with videos related to
Sort By:
Pageof 5
International Journal of Hematology|May 20, 2018
Comprehensive molecular diagnosis of Epstein-Barr virus-associated lymphoproliferative diseases using next-generation sequencingShintaro Ono, Manabu Nakayama, Hirokazu Kanegane, et al.Journal of Clinical Immunology|October 25, 2018
Clinical and Immunological Characterization of ICF Syndrome in JapanChikako Kamae, Kohsuke Imai, Tamaki Kato, et al.The Journal of Allergy and Clinical Immunology. Global|July 21, 2025
B-cell immunodeficiency associated with polynucleotide kinase 3'-phosphatase (PNKP) deficiencySanami Takada, Tsubasa Okano, Kay Tanita, et al.The Journal of Allergy and Clinical Immunology|November 16, 2016
Haploinsufficiency of TNFAIP3 (A20) by germline mutation is involved in autoimmune lymphoproliferative syndromeMasatoshi Takagi, Shohei Ogata, Hiroo Ueno, et al.The Journal of Allergy and Clinical Immunology|December 13, 2016
Abnormal hematopoiesis and autoimmunity in human subjects with germline IKZF1 mutationsAkihiro Hoshino, Satoshi Okada, Kenichi Yoshida, et al.Stem Cell Research & Therapy|June 26, 2019
Robust and highly efficient hiPSC generation from patient non-mobilized peripheral blood-derived CD34+ cells using the auto-erasable Sendai virus vectorTakashi Okumura, Yumi Horie, Chen-Yi Lai, et al.The Journal of Allergy and Clinical Immunology|February 2, 2021
Detailed analysis of Japanese patients with adenosine deaminase 2 deficiency reveals characteristic elevation of type II interferon signature and STAT1 hyperactivationHiroshi Nihira, Kazushi Izawa, Moeko Ito, et al.The Journal of Allergy and Clinical Immunology|July 19, 2016
Phosphatase and tensin homolog (PTEN) mutation can cause activated phosphatidylinositol 3-kinase δ syndrome-like immunodeficiencyYuki Tsujita, Kanako Mitsui-Sekinaka, Kohsuke Imai, et al.Science Immunology|June 19, 2021
Heterozygous OAS1 gain-of-function variants cause an autoinflammatory immunodeficiencyThomas Magg, Tsubasa Okano, Lars M Koenig, et al.Journal of Clinical Immunology|February 2, 2021
Hematopoietic Cell Transplantation with Reduced Intensity Conditioning Using Fludarabine/Busulfan or Fludarabine/Melphalan for Primary Immunodeficiency DiseasesAkira Nishimura, Yuki Aoki, Yasuyoshi Ishiwata, et al.Pageof 5